EYPT ALERT: Investigation Launched Into Eyepoint, Inc., Investors Are Encouraged To Contact KTMC Law Firm
RADNOR, Pa., Aug. 28, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP ( ), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by EyePoint, Inc. (NASDAQ: class="ticket-symbol" data-toggle="modal" href="#financial-modal">EYPT ) on behalf of investors who purchased or acquired EyePoint, Inc. securities and experienced significant financial losses.
EyePoint Reports Disappointing Phase 3 Clinical Trials
On August 17, 2026, EyePoint issued a press release "announc[ing] topline results from LUGANO, the first pivotal Phase 3 clinical trial for DURAVYUTM (vorolanib intravitreal insert) for the treatment of wet age-related macular degeneration (wet AMD)." Specifically, EyePoint disclosed that DURAVYU did not meet the prespecified primary endpoint -- change in best-corrected visual acuity versus on-label aflibercept -- in the full dataset of the company's Phase 3 LUGANO trial in wet age-related macular degeneration.
EyePoint's Stock Drops Over 66%
Following the news of EyePoint, Inc.'s poor clinical trial results, the company's stock price fell over 66%.
Investors who purchased EyePoint, Inc. (NASDAQ: EYPT ) securities and experienced losses may have legal rights under the federal securities laws.
CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS:
If you purchased or acquired EyePoint, Inc. securities and have lost money on your investment, please provide your information here: in Securities and Class Actions,, The National Law Journal's Plaintiff's Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group's Honor Roll of Most Feared Law Firms, The Legal Intelligencer's, Lawdragon's Leading Plaintiff Financial Lawyers, and Law360's Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent.
CONTACT:
Jonathan Naji, Esq.
280 King of Prussia Road
Radnor, PA 19087
(484) 270-1453
[email protected]
May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.
SOURCE Kessler Topaz Meltzer & Check, LLP
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment